“In a parallel study, the LDL from eight patients … were first treated with 80 mg/d of valsartan for 2 months … reduced susceptibility to copper ion –induced oxidation, as observed by prolongation of lag time by 23% and reduction in TBARS levels by 19%, compared with the baseline values.”